OMEGA HEALTHCARE FILES 8-K ON FINANCIAL RESULTS

TL;DR

**Omega Healthcare just dropped an 8-K with fresh financial results, so check their numbers.**

AI Summary

OMEGA HEALTHCARE INVESTORS, INC. filed an 8-K on February 7, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This filing indicates that the company is providing updated financial information, likely related to its recent performance. For investors, this matters because it offers a timely look into the company's financial health, which can influence stock price and future dividend payouts, especially for a Real Estate Investment Trust (REIT) like Omega Healthcare.

Why It Matters

This filing provides investors with crucial, up-to-date financial performance data, enabling them to assess the company's current health and make informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate new risks or significant changes.

Analyst Insight

A smart investor would review the detailed financial statements and results of operations that will be included as exhibits to this 8-K to understand the company's current financial performance and its implications for future dividends and stock value.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — the registrant filing the 8-K
• February 7, 2024 (date) — date of earliest event reported and filing date
• 303 International Circle, Suite 200 Hunt Valley, Maryland 21030 (address) — principal executive offices of the registrant
• 410-427-1700 (phone_number) — registrant's telephone number
• Maryland (state) — state of incorporation for Omega Healthcare Investors, Inc.

FAQ

Filing Documents

• ohi-20240207x8k.htm (8-K) — 32KB
• ohi-20240207xex99d1.htm (EX-99.1) — 524KB
• ohi-20240207xex99d1001.jpg (GRAPHIC) — 8KB
• 0000888491-24-000004.txt ( ) — 816KB
• ohi-20240207.xsd (EX-101.SCH) — 4KB
• ohi-20240207_def.xml (EX-101.DEF) — 3KB
• ohi-20240207_lab.xml (EX-101.LAB) — 1KB
• ohi-20240207_pre.xml (EX-101.PRE) — 11KB
• ohi-20240207x8k_htm.xml (XML) — 5KB

02 Regulation FD Disclosure

Item 2.02 Regulation FD Disclosure On February 7, 2024, Omega Healthcare Investors, Inc. ("Omega") issued a press release regarding its financial results for the quarter ended December 31, 2023. Omega's press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press release issued by the Company on February 7, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: February 7, 2024 By: /s/ Gail D. Makode Gail D. Makode Chief Legal Officer, General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR